Weight loss

Boehringer Ingelheim Advances Dual Agonist Survodutide to Phase III Trials, Demonstrating Significant Weight Loss in Phase II Study

(IN BRIEF) Pharmaceutical company Boehringer Ingelheim has declared its intention to move forward with survodutide, a dual agonist targeting the…

9 months ago

Latest research and future treatment in heart rhythm disorders to be presented at EHRA 2021

(PRESS RELEASE) Sophia Antipolis Cedex, France, 29-Mar-2021 — /EuropaWire/ — European Society of Cardiology (ESC) announces that its online scientific…

3 years ago

University of Liverpool research demonstrates the effectiveness of fibre-based dietary ingredient that makes people feel less hungry and consume less food

LIVERPOOL, 27-8-2014 — /EuropaWire/ — Scientists from the University of Liverpool have demonstrated the effectiveness of a fibre-based dietary ingredient that makes…

10 years ago